Loading...
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
Using folic acid (FA) as placebo complicates the interpretation of the findings of few RCTs evaluating safety and efficacy of hydroxychloroquine prophylaxis in COVID-19. FA is found to bind to furin-protease and spike: ACE2 interface of SARS-CoV-2. In clinical studies, FA level was lowest among seve...
Na minha lista:
| Udgivet i: | Med Hypotheses |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier Ltd.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7896118/ https://ncbi.nlm.nih.gov/pubmed/33662863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2021.110539 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|